News
Mersede Mokri, founder and CEO of MyoScan AI, was named the second-prize winner, receiving a $1,250 prize from Simon Fraser ...
A UCSF pilot study finds psilocybin therapy surprises, showing meaningful improvements in mood, cognition, and motor symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback